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The innate immune function of phagocytosis of apoptotic cells, tissue debris, pathogens,
and cancer cells is essential for homeostasis, tissue repair, ﬁghting infection, and
combating malignancy. Phagocytosis is carried out in the central nervous system (CNS)
by resident microglia and in both CNS and peripheral nervous system by recruited
macrophages. While phagocytosis proceeds, bystander healthy cells protect themselves
by sending a “do not eat me” message to phagocytes as CD47 on their surface ligates
immune inhibitory receptor SIRPα on the surface of phagocytes and SIRPα then produces
the signaling which inhibits phagocytosis. This helpful mechanism becomes harmful
when tissue debris and unhealthy cells inhibit their own phagocytosis by employing the
same mechanism. However, the inhibitory signaling that SIRPα produces has not been
fully revealed. We focus here on how SIRPα inhibits the phagocytosis of the tissue
debris “degenerated myelin” which hinders repair in axonal injury and neurodegenerative
diseases. We tested whether SIRPα inhibits phagocytosis by regulating cytoskeleton
function through paxillin and coﬁlin since (a) the cytoskeleton generates the mechanical
forces that drive phagocytosis and (b) both paxillin and coﬁlin control cytoskeleton function.
Paxillin and coﬁlin were transiently activated in microglia as phagocytosis was activated.
In contrast, paxillin and coﬁlin were continuously activated and phagocytosis augmented
in microglia in which SIRPα expression was knocked-down by SIRPα-shRNA. Further,
levels of phagocytosis, paxillin activation, and coﬁlin activation positively correlated with
one another. Taken together, these observations suggest a novel mechanism whereby
paxillin and coﬁlin are targeted to control phagocytosis by both the activating signaling that
phagocytic receptors produce by promoting the activation of paxillin and coﬁlin and the
inhibiting signaling that immune inhibitory SIRPα produces by promoting the inactivation
of paxillin and coﬁlin.
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INTRODUCTION
Phagocytosis, the engulfment and internalization of large parti-
cles by phagocytes, is an innate immune function which is carried
out in the central nervous system (CNS) parenchyma by res-
ident microglia and in both CNS parenchyma and peripheral
nervous system (PNS) nerves by recruited bone marrow-derived
macrophages. Phagocytosis is essential for homeostasis as it clears
apoptotic and aging cells, tissue repair when it removes tissue
debris, ﬁghting infection since it scavenges pathogens and com-
bating malignancy while it eliminates cancer cells. During such
phagocytosis, bystander healthy cells are protected from being
phagocytosed. CD47-SIRPα interactions provide this protection
when CD47 on the surface of healthy cells binds and activates the
immune inhibitory receptor signal regulatory protein-α (SIRPα;
also known as CD172α and SHPS-1) on the surface of phagocytes
and SIRPα then produces the signaling that inhibits phagocyto-
sis (Barclay and Brown, 2006; Matozaki et al., 2009; Oldenborg,
2013). Such observations led to deﬁne CD47 as a marker of “self”
which sends a “do not eat me”message to phagocytes (Oldenborg
et al., 2000).
This protective mechanism becomes detrimental under patho-
logical conditions when tissue debris (Gitik et al., 2011) and
malignant cells (Chao et al., 2012; Kim et al., 2012) employ CD47-
SIRPα interactions to inhibit their own clearance. We (Gitik et al.,
2011) and others thereafter (Han et al., 2012) documented in
this regard that the tissue debris “degenerated myelin” inhibits
its own phagocytosis as CD47 on degenerated myelin ligates
SIRPα on macrophages and microglia. Intact myelin is a special-
ized extension of Schwann cells in the PNS and oligodendrocytes
in the CNS, and further, it surrounds the larger diameter of
PNS and CNS axons, enabling them fast conduction of elec-
trical activity. Myelin breaks down in Wallerian degeneration
following traumatic axonal injury (Waller, 1850; Vargas and Bar-
res, 2007; Rotshenker, 2011) and in neurodegenerative diseases
such as multiple sclerosis (Stadelmann and Bruck, 2008). The
rapid phagocytosis of the tissue debris degenerated myelin so
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produced is essential since it impedes repair and exacerbates dis-
ease by arresting the regeneration of severed adult axons (David
and Aguayo, 1981), preventing remyelination (Kotter et al., 2006)
and advancing the production of membrane attack complexes that
damage nearby intact tissue (Mead et al., 2002). Thus, understand-
ing how SIRPα inhibits the phagocytosis of degenerated myelin is
of utmost importance.
Previous studies documented that SIRPα signaling involves
the recruitment of tyrosine phosphatases SHP-1 and SHP-2 to
the cytoplasmic domain of SIRPα, and subsequently, SHP-1 and
SHP-2may dephosphorylate phosphotyrosine sites in their imme-
diate downstream target molecules (Barclay and Brown, 2006;
Matozaki et al., 2009; Oldenborg, 2013). However, the molecular
events further downstream to the SIRPα/SHP-1/2 complex have
not been fully elucidated.
The phagocytosis of degenerated myelin is mediated by phago-
cytic receptors complement receptor-3 (CR3), scavenger receptor
SRA-I/II (SRA) and Fcγ receptor (FcγR) (Reichert et al., 2001;
Reichert and Rotshenker, 2003; Rotshenker, 2003). CR3 ligates
both unopsonized and C3bi-opsonized degenerated myelin (i.e.,
opsonized by complement protein C3bi), SRA ligates unopsonized
degenerated myelin, and FcγR ligates IgG-opsonized degenerated
myelin (i.e., opsonized by anti-myelin antibodies). Further, degen-
eratedmyelin can simultaneously ligate several receptors.We focus
in this study on the cytoskeleton as a potential target through
which SIRPαmay inhibit the phagocytosis of degenerated myelin
which is mediated mostly by CR3, to a lesser level by SRA, and
not at all by FcγR since phagocytosis was assayed in the absence of
anti-myelin antibodies.
We previously documented that CR3 and SRA mediated
phagocytosis of degenerated myelin involves structural changes
in phagocytes. First, ﬁlopodia and lamellipodia extend and
engulf the myelin-debris, and then, ﬁlopodia/lamellipodia retract,
and pull-in the myelin-debris into the phagocyte where it
is degraded (Hadas et al., 2012). Extension and retraction of
membrane protrusions are driven by mechanical forces that
are generated by the cytoskeleton. The production of mem-
brane protrusions depends on the remodeling of ﬁlamentous
actin (F-actin); i.e., the breakdown of old ﬁlaments and the
production of new ones (Wang et al., 2007; Bernstein and
Bamburg, 2010). Coﬁlin/ADF (actin depolymerizing factor) is
a family of proteins that controls F-actin remodeling. Active
unphosphorylated coﬁlin advances the remodeling F-actin and
thereby the production of ﬁlopodia/lamellipodia whereas inactive
phosphorylated coﬁlin (p-coﬁlin) stabilizes F-actin and thereby
reduces the production of ﬁlopodia/lamellipodia. We previously
documented in this regard that (a) ﬁlopodia/lamellipodia are
involved in the phagocytosis of degenerated myelin (Hadas et al.,
2012); (b) active unphosphorylated coﬁlin advances whereas
inactive p-coﬁlin reduces phagocytosis (Hadas et al., 2012); (c)
the small GTPase RhoA, which signals through ROCK, stabi-
lizes F-actin, and further down-regulates phagocytosis (Gitik
et al., 2010). The retraction of ﬁlopodia/lamellipodia can be
driven by mechanical forces that are generated by contraction
which is based on the interaction between F-actin and non-
muscle-myosin in which motor activity was triggered (Clark
et al., 2007; Vicente-Manzanares et al., 2009). We previously
documented in this regard that the phagocytosis of degener-
ated myelin is advanced by myosin light chain kinase (MLCK)
after it triggers motor activity in non-muscle-myosin which
then leads to F-actin/non-muscle-myosin-based contraction
(Gitik et al., 2010).
Taken that (a) active coﬁlin advances the phagocytosis of degen-
erated myelin by CR3 (an αM/β2 integrin; Hadas et al., 2012),
(b) integrins promote the activation the scaffold/adaptor protein
paxillin through focal-adhesion-kinase (FAK) and Src and, (c)
paxillin in its active phosphorylated state (p-paxillin) can indi-
rectly activate coﬁlin (Deakin and Turner, 2008), we hypothesize
that SIRPα could inhibit phagocytosis by promoting the inactiva-
tion of both paxillin and coﬁlin (Figure 1). Observations made in
this study support this working hypothesis, further suggesting that
phagocytosis is determined by the balance between CR3 and SRA
advancing phagocytosis by promoting paxillin and coﬁlin activa-
tion and SIRPα inhibiting phagocytosis by promoting paxillin and
coﬁlin inactivation.
MATERIALS AND METHODS
ANIMALS
Animals Balb/Cmice that were obtained fromHarlan (Israel) were
handled in accordance with the national research council guide
for the care and use of laboratory animals and the approval of the
institutional committee.
PRIMARY MICROGLIA
Primary microglia were isolated from brains of neonate mice as
previously described (Reichert and Rotshenker, 2003). In brief,
brains were stripped of their meninges, enzymatically dissociated,
cells plated on poly-L-lysine coated ﬂasks for 1 week, replated for
1–2 h on bacteriological plates and non-adherent cells washed
away. The vast majority (over 95%) of adherent cells are microglia
judgedbymorphology andpositive immunoreactivity toGalectin-
3/MAC-2, CR3, and F4/80 (Reichert and Rotshenker, 1996, 1999)
GENERATION OF MICROGLIA WITH STABLE REDUCED SIRPα
EXPRESSION
Generation of microglia with stable reduced SIRPα expressionwas
previously described and documented by us (Gitik et al., 2011).
Reduction of SIRPα expression was achieved through lentivi-
ral infection of wild-type Balb/C microglia with short hairpin
RNAsdirected againstmouse SIRPαmRNA(SIRPα-shRNA)using
pLKO.1 puro plasmids (Sigma, Israel). Three different shRNA
sequences were used. All were effective in reducing SIRPα expres-
sion (60, 70, and 90% of levels in wild-type microglia). The
one used in this study, as in our previous study (Gitik et al.,
2011), was the SIRPα cDNA coding sequence 5′CCGGTGGTTC-
AAAGAACTCGAGTTCTTGCCCATCTTTGAACCATTTTTG-3′.
The plasmid was transfected into a 293T-based packaging cell
line, and the resulting culture supernatant was used for lentivi-
ral infection. Infected microglia were selected on the basis of their
resistance to puromycin brought by the pLKO.1 plasmid. Levels of
SIRPα protein expression were monitored by immuno blot anal-
ysis. As a control, microglia were infected in a similar way with
the shRNA sequence 5′CTTACGCTGAGTACTTCGA-3′ against
the non-target ﬁreﬂy Luciferase gene. We refer to these microglia
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FIGURE 1 | CR3 and SRA advance the phagocytosis of degenerated
myelin by promoting the activation of paxillin and cofilin whereas
SIRPα inhibits phagocytosis by promoting the inactivation of paxillin
and cofilin (a schematic representation of the working hypothesis).
Degenerated myelin ligates simultaneously phagocytic receptors CR3 and
SRA and immune inhibitory receptor SIRPα. CR3 and SRA produce the
signaling that culminates in structural changes (marked by ellipses);
ﬁlopodia and lamellipodia ﬁrst engulf the myelin-debris as they extend and
then pull-in the myelin-debris as they retract. We hypothesize the following.
Phagocytic receptors promote paxillin activation through phosphorylation
(paxillin → p-paxillin) leading to coﬁlin activation through dephosphorylation
(p-coﬁlin → coﬁlin). In turn, coﬁlin promotes the production of ﬁlopodia and
lamellipodia and so phagocytosis is advanced. In contrast, SIRPα promotes
the inactivation of paxillin through p-paxillin dephosphorylation (p-paxillin →
paxillin) leading to coﬁlin inactivation through phosphorylation (coﬁlin →
p-coﬁlin). In turn, the production of ﬁlopodia and lamellipodia is reduced and
so phagocytosis is inhibited. Retraction of ﬁlopodia and lamellipodia is
promoted by MLCK triggering motor activity in non-muscle-myosin which
then initiates F-actin/non-muscle-myosin-based contraction (not illustrated).
Dashed lines mark indirect interactions; blue lines mark activation and red
lines inhibition of phagocytosis.
as control microglia in text and Control Luciferase (Con-Luc)
microglia in ﬁgures.
MYELIN ISOLATION
Myelin isolation frommouse brains has been previously described
(Slobodov et al., 2001) and also visualized (Gitik et al., 2011). The
isolated myelin is “degenerated myelin” since isolation involves
breakdown of intact myelin.
PHAGOCYTOSIS OF DEGENERATED MYELIN
Phagocytosis of degenerated myelin was assayed in microglia that
were plated in 96-well tissue culture plates at a density that min-
imizes cell-cell contact (0.25−1.5 × 104/well) in the presence of
Dulbecco’s Modiﬁed Eagle Medium (DMEM)/F12 supplemented
by 10% FCS. Non-adherent microglia were washed out after 2 h
and adherent microglia left to rest overnight. Next, phagocytes
were washed and degenerated myelin added in the presence of
serum for the indicated time periods. Then, unphagocytosed
degenerated myelin was washed out and levels of phagocytosis
determined by enzyme linked immunosobent assay (ELISA).
ELISA ASSAY TO QUANTIFY THE PHAGOCYTOSIS OF DEGENERATED
MYELIN
ELISA assay to quantify the phagocytosis of degenerated myelin is
based on the detection of myelin basic protein (MBP) inmicroglia
lysates. Since MBP is unique to myelin and is not produced
by phagocytes, MBP levels detected in phagocyte cytoplasm are
proportional to levels of degenerated myelin that is phagocy-
tosed. In brief, after non-phagocytosed degenerated myelin is
washed away and remaining degenerated myelin has been phago-
cytosed/internalized, phagocytes are lysed (0.05 M carbonate
buffer, pH 10), lysates transferred to high protein absorbance
plates (Nalge Nunc International, NY, USA) and levels of MBP
determined by ELISA using anti-MBP monoclonal antibody. A
detailed protocol is given in (Slobodov et al., 2001) where we also
determined that more than 95% of the detected MBP arises from
phagocytosed/internalized degenerated myelin. We further veri-
ﬁed the validity of this phagocytosis assay by documenting over
95% inhibition of the phagocytosis of degenerated myelin in the
presence of cytochalasin-D (not shown).
QUANTIFICATION OF PHAGOCYTOSIS
Quantiﬁcation of phagocytosis was carried out in the following
way.When phagocytosis by SIRPα-KDmicroglia (i.e.,microglia in
which SIRPα expression was knocked-down with SIRPα-shRNA)
was compared to phagocytosis by controlmicroglia (i.e.,microglia
infected with non-target Luciferase-shRNA), phagocytosis by each
population was ﬁrst normalized to the number of respective
microglia counted in 1 mm2 areas at the center of wells. Nor-
malizing phagocytosis to cell number is required since SIRPα-KD
and control microglia may differ in their adherence properties,
thus resulting in different number of adherent microglia even
when the same number of cells was initially seeded. To this end,
microglia in replicate plates were ﬁxed (i.e., instead of being lysed
for the phagocytosis assay), stained, and counted. Phagocyto-
sis normalized to cell number by control microglia was deﬁned
100% and phagocytosis normalized to cell number by SIRPα-KD
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microglia was calculated as percentage of phagocytosis by control
microglia. Statistical analysis was carried out as detailed in ﬁgure
legends.
IMMUNOBLOT ANALYSIS
Immunoblot analysis Microglia were plated in 10 cm tissue cul-
ture plates at a density that minimizes cell–cell contact (3 × 106
cells per plate) in the presence of DMEM supplemented by
10% FCS, and left to rest overnight. Phagocytes were washed
in fresh DMEM supplemented by 10% FCS, degenerated myelin
added in the presence of serum for the indicated time periods
and unphagocytosed degenerated myelin washed out. For lysis,
microglia were washed in PBS and lysed in ice cold lysis buffer
(Tris HCL 1 M pH 7.5, MgCl2 1 M, NaCl 4 M, 0.5% NP-40,
0.1% DTT, and 0.1% NaVa) supplemented with protease and
phosphatase inhibitors cocktail (Sigma–Aldrich, Israel), cellular
debris was removed by centrifugation, and total protein con-
tent determined using Bradford reagent (Sigma–Aldrich, Israel).
Equal protein content from whole cell lysates was separated on
SDS-PAGE to detect SIRPα, paxillin, coﬁlin, and GAPDH. Pro-
teins were blotted to nitrocellulose membranes, blocked with
10% non-fat milk or 5% BSA in TBS (Tris-buffered saline) for
1 h at RT, incubated over night at 4
◦
C in the presence of pri-
mary antibodies mouse anti-rat SIRPα/CD172α (Serotec, Oxford,
England), mouse anti-human GAPDH, rabbit anti-coﬁlin, rab-
bit anti-pS3-coﬁlin-1, and rabbit anti-pY118-paxillin (Santa Cruz
Biotechnology, USA), rabbit anti-paxillin (Cell Signaling, USA),
andmouse anti-actinmonoclonal antibody (MP biomedicals, CA,
USA). Blots werewashedwith TBST and incubatedwith respective
secondary antibodies goat anti-rat, goat anti-rabbit, and goat anti-
mouse conjugated to HRP (Jackson ImmunoReserach, USA) for
40-min at RT. Proteins were visualized with EZ-ECL kit for HRP
detection (Beit Haemek, Israel). The intensities of immunoblot
bands were determined by ImageJ software and quantiﬁcation
and statistical analysis was carried out as detailed in ﬁgure
legends.
RESULTS
SIRPα PROMOTES THE INACTIVATION OF COFILIN
Wepreviously documented the followingwith regard to the phago-
cytosis of degenerated myelin by microglia in the absence of
anti-myelin antibodies: (a) phagocytosis is mostly mediated by
CR3 and to a lesser degree by SRA (Rotshenker, 2003), (b) phago-
cytosis is advanced by coﬁlin (Hadas et al., 2012), (c) phagocytosis
is inhibited by SIRPα (Gitik et al., 2011). Thus, SIRPα could inhibit
phagocytosis by promoting the inactivation of coﬁlin. In this case,
reducing SIRPα in phagocytes is expected to promote the acti-
vation of coﬁlin by shifting the balance from inactive p-coﬁlin
(coﬁlin phosphorylated at serine site S3) to active unphosphory-
lated coﬁlin (coﬁlin) concurrent with augmenting phagocytosis.
We addressed this issue by examining p-coﬁlin levels before and
during phagocytosis in microglia in which SIRPα expression was
knocked-down (SIRPα-KD) by lentiviral infection with SIRPα-
shRNA, and further, in control microglia that were similarly
infected with the non-target ﬁreﬂy Luciferase-shRNA.
Indeed, SIRPα levels were reduced (Figure 2A) and phago-
cytosis was augmented (Figure 2B) in SIRPα-KD microglia
FIGURE 2 |The phagocytosis of degenerated myelin is augmented in
SIRPα-KD microglia. (A) A representative (one of three) immunoblot of
SIRPα and GAPDH. SIRPα levels are reduced in Balb/C microglia infected
with SIRPα-shRNA (SIRPα-KD) compared with control microglia infected
with non-target Luciferase-shRNA (Con-Luc). (B) Phagocytosis of
degenerated myelin is augmented in SIRPα-KD microglia compared with
phagocytosis by control microglia (Con-Luc). Phagocytosis by SIRPα-KD
microglia was calculated as a percentage of phagocytosis by control
microglia that was deﬁned as 100%. Values of individual experiments each
performed in triplicates and averages ± SE are given. Signiﬁcance of
difference by Mann–Whitney is ***p < 0.001.
compared with control microglia, thus conﬁrming our previously
reported observations (Gitik et al., 2011). Levels of p-coﬁlin
were then determined by immunoblot analysis using an anti-
body raised against coﬁlin that is phosphorylated at serine site
S3 (Figures 3A,C). Levels of p-coﬁlin were reduced in control
microglia after 10 min of phagocytosis down to about 75% of
those in non-phagocytosing control microglia. Then, after 30 min
of phagocytosis, levels of p-coﬁlin returned to and rose above their
initial levels in non-phagocytosing control microglia. These ﬁnd-
ings conﬁrm our previously reported observations (Hadas et al.,
2012).
SIRPα-KD microglia differed from control microglia with
respect to p-coﬁlin levels before and during phagocytosis
(Figures 3B,C). Levels of p-coﬁlin were reduced in non-
phagocytosing SIRPα-KD microglia down to about 75% of those
in non-phagocytosing control microglia. After 10 and 30 min
of phagocytosis, p-coﬁlin levels were reduced further down to
about 60% of those in non-phagocytosing control microglia.
Taken together, coﬁlin was transiently activated during prolonged
phagocytosis in control microglia but continuously activated in
SIRPα-KD microglia, suggesting that normally SIRPα promotes
the inactivation of coﬁlin through serine (S3) phosphorylation.
SIRPα PROMOTES THE INACTIVATION OF PAXILLIN
Taken that the SIRPα/SHP-1/2 complex dephosphorylates phos-
photyrosine sites in its immediate target molecules (Barclay
and Brown, 2006; Matozaki et al., 2009; Oldenborg, 2013) and
our present ﬁndings that SIRPα promotes coﬁlin inactivation
by serine phosphorylation, SIRPα could not have inactivated
coﬁlin directly. However, SIRPα could inactivate coﬁlin indi-
rectly through paxillin. This proposition is based on previous
observations that paxillin is activated by tyrosine phosphorylation
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FIGURE 3 | Cofilin activation is transient in phagocytosing control
microglia but continuous in phagocytosing SIRPα-KD microglia.
Immunoblot analysis of phosphorylated and total coﬁlin-1 (p- andT-coﬁlin) in
(A) control (Con-Luc) and (B) SIRPα-KD microglia before the onset of
phagocytosis (time 0), and after 10 and 30 min of phagocytosis. The
antibodies used for immunoblot analysis identify coﬁlin and coﬁlin-1 that is
phosphorylated at S3. (C) Quantitation of the ratio p/T based on
immunoblot analysis. The ratio p/T in non-phagocytosing Con-Luc microglia
(i.e., at time 0) was deﬁned 100%.Then, p/T in all other non-phagocytosing
and phagocytosing microglia was calculated as percentage of p/T in
non-phagocytosing Con-Luc microglia. Average values ±SEM of four to six
experiments, each performed in duplicates, are given. Signiﬁcance of
differences between initial values at 0 min and those at 10 and 30 min by
one way ANOVA and the Dunnet post test are *p < 0.05 and ***p < 0.001
for Con-Luc microglia and §p < 0.05 for SIRPα-KD microglia. Signiﬁcance of
difference between Con-Luc and SIRPα-KD microglia by two way ANOVA
and the Bonferroni post test are #p < 0.05 and ###p < 0.001. Signiﬁcance
of difference between 10 and 30 min in Con-Luc microglia by one way
ANOVA and theTukey’s post test is p < 0.001 (not marked).
(paxillin phosphorylated at tyrosine site Y118), and further, that
p-paxillin can indirectly activate coﬁlin (Deakin and Turner,
2008). Thus if SIRPα promotes the inactivation of paxillin, then
levels of active p-paxillin are expected to be higher in SIRPα-KD
microglia than in control microglia.
Levels of p-paxillin were determined by immunoblot analysis
using an antibody raised against paxillin which is phosphorylated
at tyrosine site Y118 (Figures 4A,C). Levels of p-paxillin increased
in controlmicroglia to about 160%of those in non-phagocytosing
control microglia after 10 min of phagocytosis. Then, after 30 min
of phagocytosis, p-paxillin levels decreased signiﬁcantly to about
120% of those in non-phagocytosing control microglia.
SIRPα-KD microglia differed from control microglia with
respect to p-paxillin levels before and during phagocyto-
sis (Figures 4B,C). Levels of p-paxillin were about 145%
higher in non-phagocytosing SIRPα-KD microglia than in non-
phagocytosing control microglia. After 10 and 30 min of phago-
cytosis, levels of p-paxillin increased further to about 160 and
170% of those in non-phagocytosing control microglia. Taken
together, paxillin was transiently activated during prolonged
phagocytosis in control microglia and continuously activated in
SIRPα-KD microglia, suggesting that normally SIRPα promotes
the inactivation of paxillin through phosphotyrosine (pY118)
dephosphorylation.
PAXILLIN ACTIVATION, COFILIN ACTIVATION AND PHAGOCYTOSIS
POSITIVELY CORRELATE WITH ONE ANOTHER
It has been suggested that active p-paxillin can indirectly activate
coﬁlin by promoting the transition from inactive p-coﬁlin to active
unphosphorylated coﬁlin (Deakin and Turner, 2008). If this is the
case during the phagocytosis of degenerated myelin, then levels
of active p-paxillin and levels of inactive p-coﬁlin should nega-
tively correlate with one another during phagocytosis, and further,
phagocytosis augmentation should positively correlate with the
activation of both paxillin and coﬁlin. Indeed, control microglia
displayed transient increases in p-paxillin and transient decreases
in p-coﬁlin during phagocytosis, and further, SIRPα-KDmicroglia
exhibited higher levels of p-paxillin and lower levels of p-coﬁlin
compared with control microglia both before and throughout
phagocytosis which was augmented in SIRPα-KD microglia com-
pared with control microglia. To obtain a quantitative measure to
these apparent correlations, all values of p-paxillin and p-coﬁlin
presented in Figures 3 and 4 were subjected to linear regression
and correlation analysis (Figure 5). Levels of p-paxillin and p-
coﬁlin displayed signiﬁcant (p < 0.05) negative correlation with
an r2 value of 0.79. Thus paxillin activation (reﬂected by higher
levels of p-paxillin) and coﬁlin activation (reﬂected by lower levels
of p-coﬁlin) positively correlated with one another. Since levels
of phagocytosis increased in SIRPα-KD microglia compared with
control microglia at the same time as levels of both paxillin and
coﬁlin activation increased, all three (i.e., levels of phagocyto-
sis, paxillin activation, and coﬁlin activation) positively correlated
with one another.
DISCUSSION
Observations made in this study suggest a novel mecha-
nism whereby paxillin and coﬁlin are targeted to control the
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FIGURE 4 | Paxillin activation is transient in phagocytosing control
microglia but continuous in phagocytosing SIRPα-KD microglia.
Immunoblot analysis of p- andT-paxillin in (A) control (Con-Luc), and
(B) SIRPα-KD microglia before the onset of phagocytosis (time 0), and after
10 and 30 min of phagocytosis. The antibodies used for immunoblot
analysis identify paxillin and paxillin that is phosphorylated at Y118. (C)
Quantitation of the ratio p/T based on immunoblot analysis. The ratio p/T in
non-phagocytosing Con-Luc microglia (i.e., at time 0) was deﬁned 100%.
Then p/T in all other non-phagocytosing and phagocytosing microglia was
calculated as percentage of p/T in non-phagocytosing Con-Luc microglia.
Average values ±SEM of four to eight experiments, each performed in
duplicates, are given. Signiﬁcance of differences between initial values at
0 min and those at 10 and 30 min by one way ANOVA and the Dunnet post
test are *p < 0.05 and ***p < 0.001 for Con-Luc microglia. Signiﬁcance of
difference between Con-Luc and SIRPα-KD microglia by two way ANOVA
and the Bonferroni post test is ###p < 0.001. Signiﬁcance of difference
between 10 and 30 min in Con-Luc microglia by one way ANOVA and the
Tukey’s post test is p < 0.01 (not marked).
phagocytosis of degenerated myelin by both the activating
signaling which phagocytic receptors CR3 and SRA produce
and the inhibiting signaling that immune inhibitory receptor
SIRPα produces. In this regard, phagocytic receptors advance
FIGURE 5 |The activation of paxillin and cofilin are linked. All values of
active p-paxillin and inactive p-coﬁlin that are presented in Figures 3 and 4
were subjected to linear regression and correlation analysis. The two
display a negative correlation with an r2 value of 0.79. Signiﬁcance of
correlation by the Pearson double tailed test is p < 0.05.
phagocytosis by promoting the activation of paxillin and coﬁlin
whereas immune inhibitory receptor SIRPα inhibits phagocytosis
by promoting the inactivation of the two.
The activation of phagocytosis by paxillin and coﬁlin is sug-
gested by the ﬁndings that phagocytosis positively correlates with
the activation of both paxillin and coﬁlin in both control and
SIRPα-KD microglia. In control microglia, paxillin and coﬁlin
were activated concurrent with the activation of phagocytosis, and
in SIRPα-KD microglia, levels of paxillin and coﬁlin activation
increased simultaneously with the increase in phagocytosis.
The role coﬁlin plays in the phagocytosis of degeneratedmyelin
was recently reported and discussed by us (Hadas et al., 2012).
Coﬁlin advances phagocytosis by promoting the remodeling of F-
actin and thereby the production of ﬁlopodia/lamellipodia which
engulf the myelin-debris. We presently suggest that coﬁlin acti-
vation is promoted by paxillin. This proposition is based on the
observations that paxillin can indirectly activate coﬁlin (Deakin
and Turner, 2008) and our present ﬁndings that levels of paxillin
activation and levels of coﬁlin activation positively correlated with
one another. The involvement of p-paxillin in signaling phagocy-
tosis by CR3 and SRA which is documented here could also take
place in signaling phagocytosis by FcγR since paxillin is tyrosine
phosphorylated during FcγR mediated phagocytosis (Greenberg
et al., 1994).
That SIRPα inhibits the phagocytosis of degenerated myelin
by promoting the inactivation of both paxillin and coﬁlin is sug-
gested by the synchronized occurrence of three events in SIRPα-
KD microglia. First, phagocytosis is augmented in SIRPα-KD
microglia compared with control microglia; second, the activa-
tion of both paxillin and coﬁlin increases in non-phagocytosing
as well as in phagocytosing SIRPα-KD microglia compared with
non-phagocytosing and phagocytosing control microglia; third,
the kinetics of the activation of both paxillin and coﬁlin switched
from transient in phagocytosing control microglia to continuous
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in phagocytosing SIRPα-KD microglia. SIRPα dependent inac-
tivation of paxillin and coﬁlin was not reported before for any
of the functions that SIRPα is involved in. We further raise the
possibility that SIRPα could directly inactivate paxillin through
dephosphorylation since paxillin is activated through tyrosine
phosphorylation (Deakin and Turner, 2008) and the SIRPα/SHP-
1/2 complex dephosphorylates phosphotyrosine sites (Barclay and
Brown, 2006; Matozaki et al., 2009; Oldenborg, 2013).
In conclusion, the phagocytosis of degenerated myelin is deter-
mined by the balance between the signaling produced by CR3
and SRA which activates paxillin and coﬁlin and the signaling
produced by SIRPα which inactivates paxillin and coﬁlin. SIRPα
could also target paxillin and coﬁlin while inhibiting phagocytosis
which ismediated by additional phagocytic receptors such as FcγR
(Oldenborg et al., 2001) and during the phagocytosis of particles
other thanmyelin-debris such as aging red blood cells (Oldenborg
et al., 2000) and tumor cells (Chao et al., 2012; Kim et al., 2012).
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